Streaming issues? Report here
Refilwe Moloto 2019 1500 BW Refilwe Moloto 2019 1500 BW
Breakfast with Refilwe Moloto
06:00 - 09:00
volume_up
volume_mute

Up Next: The Morning Review with Lester Kiewit
See full line-up
Breakfast with Refilwe Moloto
06:00 - 09:00
Home
arrow_forward
Business
fiber_manual_record
Local
fiber_manual_record
Africa

30% of Africa's vaccine requirements must be procured from local producers - AU

15 June 2022 7:58 PM
Tags:
The Money Show
Aspen
Aspen Pharmacare
Bruce Whitfield
Johnson & Johnson
vaccine
Stavros Nicolaou
Aspen vaccine
vaccination in Africa

Bruce Whitfield talks to Aspen Pharmacare's Stavros Nicolaou who's been attending an African Union meeting in Addis Ababa.
© Dan Magiore/123rf

The Aspen Pharmacare Group's Stavros Nicolaou talks to Bruce Whitfield from Addis Ababa, where he's been attending an African Union (AU) meeting on future COVID-19 vaccine production on the continent.

Nicolaou (Senior Executive for Strategic Trade Development) says the last few months have been disappointing not only from Aspen's viewpoint but more broadly for the continent as a whole.

The South African drugmaker has warned that its COVID-19 vaccination plant in Gqeberha could be forced to shut down after receiving zero orders.

Related stories:


Africa will lose out if Gqeberha COVID-19 vaccine plant closes, warns Aspen exec

Aspen SA finally signs deal with J & J to produce own branded Covid vaccine

Africa breakthrough': Aspen SA to produce own branded vaccine in deal with J&J


There's a clear statement of intent from the African Union about what needs to happen says Nicolaou.

... there's an express call on the international procurers... to procure a minimum of 30% of the continent's vaccine requirements from African producers.

Stavros Nicolaou, Senior Executive for Strategic Trade Development - Aspen Pharmacare Group

All the stakeholders were present [at the meeting] including the international procurement agencies... regulatory agencies were there... so it was representative of all the stakeholders...

Stavros Nicolaou, Senior Executive for Strategic Trade Development - Aspen Pharmacare Group

The next step is the outcome of the past two days will get recorded, will get sent to the African Union COVID Commission and will then serve for ratification before the AU Heads of State on the 17th of July.

Stavros Nicolaou, Senior Executive for Strategic Trade Development - Aspen Pharmacare Group

Listen to Nicolaou's update on The Money Show:




15 June 2022 7:58 PM
Tags:
The Money Show
Aspen
Aspen Pharmacare
Bruce Whitfield
Johnson & Johnson
vaccine
Stavros Nicolaou
Aspen vaccine
vaccination in Africa

More from Business

More from Local

More from Africa